Levetiracitam Tablets, Usp-figure07 (Levetiracetam Tablets Usp 1)
Levetiracetam Tablet, Film Coated
Product Images NDC 65162-538
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 65162-538). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
23 (Levetiracetam Tablets Usp 10)
Levetiracetam Tablets, USP is a medicine that contains 500 mg of Levetiracetam, USP. Each patient taking this medicine is required to receive the accompanying Medication Guide. The recommended storage temperature for this medicine is between 20" to 25°C (68" to 77°F) with excursions permitted between 15" to 30°C. It should be dispensed by a pharmacist in a tight, light-resistant container with a child-resistant closure. The detailed dosage recommendation is provided in the package insert. This medicine is manufactured by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, and distributed by Rev. 11-2017-01.*
26 (Levetiracetam Tablets Usp 11)
This is a medication description for Levetiracetam Tablets, USP containing 750mg of Levetiracetam. It includes the NDC code and recommended dosage as well as storage instructions. Pharmacists are instructed to dispense the tablets in a light-resistant container and provide the accompanying Medication Guide. The medication is distributed by Amneal Pharmaceuticals LLC.*
29 (Levetiracetam Tablets Usp 12)
This is a description of a medication called Levetiracetam, which comes in tablet form with a strength of 1000mg. The typical dosage is described in the package insert. It should be stored at a specific temperature range and dispensed in a light-resistant container with child-resistant closure. Additionally, it is required that each patient receives a Medication Guide from the pharmacist. The medication is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*
9596f2fe-figure-01 (Levetiracetam Tablets Usp 2)
20 (Levetiracetam Tablets Usp 3)
14 (Levetiracetam Tablets Usp 4)
Levetiracetam Tablets Usp 5
This text represents the results of a clinical trial study comparing the effectiveness of placebo and levetiracetam 3000 mg/day in treating a certain medical condition. The results indicate that 39.4% of the patients who received placebo reported improvement, while 40% of those who received levetiracetam reported improvement. 35% of the patients had an unknown status. Additionally, 14.4% of patients experienced side effects. A total of 104 participants were in the placebo group and 180 in the levetiracetam group.*
54 (Levetiracetam Tablets Usp 6)
This text appears to be a table or chart showing percentages and patient numbers for two groups of patients receiving different treatments, placebo and levetiracetam. The numbers may represent the percentage of patients who experienced a certain outcome, but no information is given about what that outcome is. Without additional context or information, it is not possible to provide a more specific description or interpretation.*
78 (Levetiracetam Tablets Usp 7)
This text provides information on the percentage of patients who received a placebo (N=51) or Levetiracetam (N=58). The table indicates that Levetiracetam had a statistically significant effect compared to the placebo, but there is no additional context provided.*
10 (Levetiracetam Tablets Usp 8)
20 (Levetiracetam Tablets Usp 9)
This is a medication used for treating epilepsy and seizures called Levetiracetam. It comes in the form of tablets containing 120 tablets with an NDC code of 65162-528-16. The medication guide that comes with this medicine needs to be provided to each patient. The storage requirements of this medicine are within 20 to 25C with excursions allowed between 15 to 30C. The medication needs to be dispensed in a light-resistant container with a child-proof closure. It is distributed by Amneal Pharmaceuticals LLC, and the recommended dosage can be found in the package insert.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
